Document is current

Article History

Received: 15 July 2025

Revised: 26 August 2025

Accepted: 13 September 2025

First Online: 8 October 2025

Compliance with ethical standards

:

: The scientific guarantor of this publication is Francesco Sardanelli.

: F. Sardanelli has been vice president of the Quality Assurance Scheme Development Group of the European Commission Initiative on Breast Cancer from 2015 to 2024. He received research grants from Bayer AG, Bracco Imaging, and GE Healthcare, participated in ad hoc advisory board meetings for Bayer AG, Bracco Imaging, and GE Healthcare, and held sponsored talks for Bayer AG, Bracco Imaging, Esaote, and Siemens Healthineers. In addition, he is Scientific PI of the BreastSCan project “Pan-European Breast Image Platform for Advanced AI-based Breast Cancer Screening” funded by the European Commission (EU4H-2024-PJ-02-1). G. Scaperrotta received research grants from Fuji Film, Hologic, and Becton Dickinson and participated in ad hoc advisory board meetings for the study and development of technologies for breast diagnostics and interventions. In addition, he is local PI at the Fondazione IRCCS Istituto Nazionale dei Tumori for BreastSCan project “Pan-European Breast Image Platform for Advanced AI-based Breast Cancer Screening” funded by the European Commission (EU4H-2024-PJ-02-1).

: No statistical methods were necessary for this paper.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.